byiShook Opinion
Feb 6, 2025 - 11:35
Bristol Myers walloped sales views Thursday, but Bristol Myers Squibb stock took a hit on a light outlook hamstrung by generic competition. The post Bristol Myers Wallops Fourth-Quarter Views, But Shares Slide On 2025 Outlook appeared first on Investor's Business Daily.
Bristol Myers walloped sales views Thursday, but Bristol Myers Squibb stock took a hit on a light outlook hamstrung by generic competition.
The post Bristol Myers Wallops Fourth-Quarter Views, But Shares Slide On 2025 Outlook appeared first on Investor's Business Daily.